Invesaro

Stocks Comparison

Cardiff Lexington vs Teladoc Health: revenue, profit, margins and growth compared

Cardiff Lexington brought in $11.5M of revenue in fiscal 2025, Teladoc Health $2.5B in fiscal 2025. Revenue changed by +39.5% at Cardiff Lexington and -1.5% at Teladoc Health on the year before, so Cardiff Lexington grew faster. Cardiff Lexington kept -47.7% of its revenue as net profit, Teladoc Health -7.9%.

Side by side, latest fiscal year

CDIXTDOC
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$11.5M$2.5B
Revenue growth+39.5%-1.5%
Net income-$5.5M-$200.3M
Net margin-47.7%-7.9%
Free cash flown/a$285.5M
Free cash flow marginn/a11.3%
Earnings per share (diluted)n/a-$1.14
Cash$318.5K$781.1M
Debt$18.6Mn/a
Price to earningsn/an/a
Market value$6.6M$1.1B
Dividend yieldn/an/a
Rank by revenue in sector#508 of 742 · Health care#102 of 742 · Health care

Over the years

Revenue
CDIX FY2018: $2.2MCDIX FY2019: $4.5MCDIX FY2020: $3.5MCDIX FY2021: $9.9MCDIX FY2022: $10.7MCDIX FY2023: $11.9MCDIX FY2024: $8.3MCDIX FY2025: $11.5MTDOC FY2018: $417.9MTDOC FY2019: $553.3MTDOC FY2020: $1.1BTDOC FY2021: $2BTDOC FY2022: $2.4BTDOC FY2023: $2.6BTDOC FY2024: $2.6BTDOC FY2025: $2.5BFY18FY19FY20FY21FY22FY23FY24FY25
CDIX $11.5MTDOC $2.5B
Net income
CDIX FY2018: -$6.3MCDIX FY2019: -$7.2MCDIX FY2020: -$2.8MCDIX FY2021: $666.3KCDIX FY2022: -$5.4MCDIX FY2023: $3MCDIX FY2024: -$3.3MCDIX FY2025: -$5.5MTDOC FY2018: -$97.1MTDOC FY2019: -$98.9MTDOC FY2020: -$485.1MTDOC FY2021: -$428.8MTDOC FY2022: -$13.7BTDOC FY2023: -$220.4MTDOC FY2024: -$1BTDOC FY2025: -$200.3MFY18FY19FY20FY21FY22FY23FY24FY25
CDIX -$5.5MTDOC -$200.3M
Net margin
CDIX FY2018: -281.3%CDIX FY2019: -158.1%CDIX FY2020: -82.2%CDIX FY2021: 6.7%CDIX FY2022: -50.8%CDIX FY2023: 25.5%CDIX FY2024: -39.9%CDIX FY2025: -47.7%TDOC FY2018: -23.2%TDOC FY2019: -17.9%TDOC FY2020: -44.3%TDOC FY2021: -21.1%TDOC FY2022: -567.5%TDOC FY2023: -8.5%TDOC FY2024: -39.0%TDOC FY2025: -7.9%FY18FY19FY20FY21FY22FY23FY24FY25
CDIX -47.7%TDOC -7.9%
Revenue growth
CDIX FY2019: +103.9%CDIX FY2020: -24.0%CDIX FY2021: +186.1%CDIX FY2022: +8.2%CDIX FY2023: +10.8%CDIX FY2024: -30.2%CDIX FY2025: +39.5%TDOC FY2019: +32.4%TDOC FY2020: +97.7%TDOC FY2021: +85.8%TDOC FY2022: +18.4%TDOC FY2023: +8.1%TDOC FY2024: -1.3%TDOC FY2025: -1.5%FY19FY20FY21FY22FY23FY24FY25
CDIX +39.5%TDOC -1.5%
Free cash flow
CDIX FY2018: -$2MCDIX FY2020: -$903.4KCDIX FY2021: -$853.5KCDIX FY2022: -$1.2MTDOC FY2018: -$8.9MTDOC FY2019: $26.4MTDOC FY2020: -$57.5MTDOC FY2021: $185.5MTDOC FY2022: $172.8MTDOC FY2023: $338.6MTDOC FY2024: $282.9MTDOC FY2025: $285.5MFY18FY19FY20FY21FY22FY23FY24FY25
CDIX -$1.2MTDOC $285.5M

Fiscal years as each company reports them; the two may end in different months.

Questions about Cardiff Lexington and Teladoc Health

Which is bigger by revenue, Cardiff Lexington or Teladoc Health?

Teladoc Health is bigger by revenue: $2.5B in fiscal 2025, against $11.5M for Cardiff Lexington in fiscal 2025.

Which keeps more of its revenue as profit, Cardiff Lexington or Teladoc Health?

Cardiff Lexington had a net margin of -47.7% in fiscal 2025; Teladoc Health had -7.9% in fiscal 2025.

Which grew revenue faster, Cardiff Lexington or Teladoc Health?

In their latest fiscal years revenue changed by +39.5% at Cardiff Lexington and -1.5% at Teladoc Health.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies